Susceptibility Site A March (%) Site B March (%) Site A June (%) Site B June (%) Site A
Oct (%)
Site B Nov (%) Total (%)
MDR, resistant to 3 or more classes of antimicrobial agent 65/118 (55%) 47/64 (73%) 68/78 (87%) 32/48 (67%) 50/77 (65%) 21/84 (25%) 224/469 (60%)
Susceptible to all 11 antimicrobial agents 6/25 (24%) 2/25 (8%) 2/25 (8%) 2/25 (8%) 5/25 (20%) 8/25 (32%) 25/469 (5%)
Reduced susceptibility to 1 antimicrobial agent 15/66 (23%) 6/66 (9%) 2/66 (3%) 3/66 (5%) 8/66 (12%) 32/66 (48%) 66/469 (14%)
Reduced susceptibility to 2 antimicrobial agents 26/83 (31%) 9/83 (11%) 4/83 (5%) 8/83 (10%) 13/83 (16%) 23/83 (28%) 83/469 (18%)
Reduced susceptibility to 3 antimicrobial agents 20/73 (27%) 9/73 (12%) 8/73 (11%) 10/73 (14%) 11/73 (15%) 15/73 (21%) 73/469 (16%)
Reduced susceptibility to 4 antimicrobial agents 15/46 (33%) 13/46 (28%) 1/46 (2%) 3/46 (7%) 10/46 (22%) 4/46 (9%) 46/469 (10%)
Reduced susceptibility to 5 antimicrobial agents 11/46 (24%) 4/46 (9%) 10/46 (22%) 7/46 (15%) 12/46 (26%) 2/46 (4%) 46/469 (10%)
Reduced susceptibility to 6 antimicrobial agents 13/33 (39%) 5/33 (15%) 6/33 (18%) 3/33 (9%) 6/33 (18%) 0/33 (0%) 33/469 (7%)
Reduced susceptibility to 7 antimicrobial agents 8/26 (31%) 2/26 (8%) 8/26 (31%) 4/26 (15%) 4/26 (15%) 0/26 (0%) 26/469 (6%)
Reduced susceptibility to 8 antimicrobial agents 1/25 (4%) 2/25 (8%) 12/25 (48%) 6/25 (24%) 4/25 (16%) 0/25 (0%) 25/469 (5%)
Reduced susceptibility to 9 antimicrobial agents 2/14 (14%) 1/14 (7%) 7/14 (50%) 1/14 (7%) 3/14 (21%) 0/14 (0%) 14/469 (3%)
Reduced susceptibility to 10 antimicrobial agents 1/18 (6%) 6/18 (33%) 10/18 (56%) 0/18 (0%) 1/18 (6%) 0/18 (0%) 18/469 (4%)
Reduced susceptibility to 11 antimicrobial agents 0/14 (0%) 5/14 (36%) 8/14 (57%) 1/14 (7%) 0/14 (0%) 0/14 (0%) 14/469 (3%)